Literature Review
Volume 16 Issue 3 - 2021
Coffee as a Potential Nutraceutical
Zhi Jue Kuan, Nabil Amir-Hamzah and Maurice HT Ling*
School of Applied Sciences, Temasek Polytechnic, Singapore
*Corresponding Author: Maurice HT Ling, School of Applied Sciences, Temasek Polytechnic, Singapore.
Received: February 02, 2021; Publised: February 27, 2021


Global coffee production nearly doubled over the last decade, making coffee one of the most popular beverage in current society. However, recent consumer studies suggest concerns of potential health detriments from regular coffee consumption. Given its popularity, any health benefits or detriment can have substantial public health impact. Here, we examined several potential benefits and risks with regards to coffee drinking. Evidence is non-conclusive in several cases and warrants further studies. Despite so, there is likely more health benefits than harm, especially when moderation is applied. Hence, we are in the view that coffee is a potential nutraceutical when consumed in moderation and with adequate hydration.


Keywords: Coffee; Nutraceutical; Health Complications


    1. Samoggia A and Riedel B. “Consumers’ Perceptions of Coffee Health Benefits and Motives for Coffee Consumption and Purchasing”. Nutrients3 (2019): 653.
    2. National Coffee Association. National Coffee Data Trends 2020. National Coffee Association; 2020. (NCDT Market Research Series) (2020).
    3. National Coffee Association. The Good Things in Life: Coffee as Part of a Healthy Diet and Lifestyle. National Coffee Association (2016).
    4. All Japan Coffee Association. Concerning Japanese regulation (Positive List System) of agricultural chemicals for green coffee beans.
    5. Richards G and Smith A. “Caffeine Consumption and Self-Assessed Stress, Anxiety, and Depression in Secondary School Children”. Journal of Psychopharmacology 12 (2015): 1236-1247.
    6. Coffee and Caffeine Genetics Consortium Cornelis MC., et al. “Genome-Wide Meta-Analysis Identifies Six Novel Loci Associated with Habitual Coffee Consumption”. Molecular Psychiatry 5 (2015): 647-656.
    7. Nakagawa-Senda H., et al. “A Genome-Wide Association Study in the Japanese Population Identifies the 12q24 Locus for Habitual Coffee Consumption: The J-MICC Study”. Scientific Reports 1 (2018): 1493.
    8. Zhang X-Y and Zhang P-Y. “Gastric Cancer: Somatic Genetics as a Guide to Therapy”. Journal of Medical Genetics 5 (2017): 305-312.
    9. Yusefi AR., et al. “Risk Factors for Gastric Cancer: A Systematic Review”. Asian Pacific Journal of Cancer Prevention 3 (2018): 591-603.
    10. Marmot M., et al. “Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective”. Washington DC, USA: World Cancer Research Fund/American Institute for Cancer Research (2007).
    11. Li L., et al. “Coffee Consumption and the Risk of Gastric Cancer: A Meta-Analysis of Prospective Cohort Studies”. BMC Cancer 15 (2015): 733.
    12. Parra-Lara LG., et al. “Coffee Consumption and Its Inverse Relationship with Gastric Cancer: An Ecological Study”. Nutrients10 (2020): 3028.
    13. Tareke E., et al. “Analysis of Acrylamide, A Carcinogen Formed in Heated Foodstuffs”. Journal of Agricultural and Food Chemistry 17 (2002): 4998-5006.
    14. Schouten MA., et al. “Acrylamide Formation and Antioxidant Activity in Coffee During Roasting - A Systematic Study”. Food Chemistry 343 (2021): 128514.
    15. Nehlig A and Cunha RA. “The Coffee-Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in Isolation”. Nutrients10 (2020): 3141.
    16. Bułdak RJ., et al. “The Impact of Coffee and Its Selected Bioactive Compounds on the Development and Progression of Colorectal Cancer In Vivo and In Vitro”. Molecules12 (2018): 3309.
    17. Stalder R., et al. “A Carcinogenicity Study of Instant Coffee in Swiss Mice”. Food and Chemical Toxicology 12 (1990): 829-837.
    18. Soares PV., et al. “Coffee, but Neither Decaffeinated Coffee nor Caffeine, Elicits Chemoprotection Against a Direct Carcinogen in the Colon of Wistar Rats”. Nutrition and Cancer 4 (2019): 615-623.
    19. Gan Y., et al. “Association of Coffee Consumption with Risk of Colorectal Cancer: A Meta-Analysis of Prospective Cohort Studies”. Oncotarget 12 (2017): 18699-186711.
    20. Magliano DJ., et al. “Trends in Incidence of Total or Type 2 Diabetes: Systematic Review”. British Medical Journal 366 (2019): l5003.
    21. Rhee EJ. “Diabetes in Asians”. Endocrinology and Metabolism 3 (2015): 263-269.
    22. Shi X., et al. “Acute Caffeine Ingestion Reduces Insulin Sensitivity in Healthy Subjects: A Systematic Review and Meta-Analysis”. Nutrition Journal 1 (2016): 103.
    23. Thong FSL and Graham TE. “Caffeine-Induced Impairment of Glucose Tolerance is Abolished by β-Adrenergic Receptor Blockade in Humans”. Journal of Applied Physiology 6 (2002): 2347-2352.
    24. Jiang X., et al. “Coffee and Caffeine Intake and Incidence of Type 2 Diabetes Mellitus: A Meta-Analysis of Prospective Studies”. European Journal of Nutrition 1 (2014): 25-38.
    25. Carlström M and Larsson SC. “Coffee Consumption and Reduced Risk of Developing Type 2 Diabetes: A Systematic Review with Meta-Analysis”. Nutrition Reviews 6 (2018): 395-417.
    26. Lim Y., et al. “The Effect of Coffee Consumption on the Prevalence of Diabetes Mellitus: The 2012-2016 Korea National Health and Nutrition Examination Survey”. Nutrients10 (2019): 2377.
    27. Noh J. “The Diabetes Epidemic in Korea”. Endocrinology and Metabolism Seoul Korea 3 (2016): 349-353.
    28. Smits P., et al. “The Role of Epinephrine in the Circulatory Effects of Coffee”. Clinical Pharmacology and Therapeutics 4 (1986): 431-437.
    29. Van Zijderveld GA., et al. “Adrenaline and the Relationship Between Neurosomatism, Aerobic Fitness and Mental Task Performance”. Biological Psychology 3 (1993): 157-181.
    30. Ziemba A., et al. “Changes in the Hormonal Profile of Athletes following a Combat Sports Performance”. BioMed Research International (2020): 9684792.
    31. Trexler ET., et al. “Effects of Coffee and Caffeine Anhydrous on Strength and Sprint Performance”. European Journal of Sport Science 6 (2016): 702-710.
    32. Marques AC., et al. “Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study”. Nutrients6 (2018): 657.
    33. Goldstein ER., et al. “International Society of Sports Nutrition Position Stand: Caffeine and Performance”. Journal of the International Society of Sports Nutrition 1 (2010): 5.
    34. Pickering C and Kiely J. “Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition”. Sports Medicine 1 (2018): 7-16.
    35. Clarke ND., et al. “Coffee Ingestion Improves 5 km Cycling Performance in Men and Women by a Similar Magnitude”. Nutrients 11 (2019): 2575.
    36. Haskell-Ramsay CF., et al. “The Acute Effects of Caffeinated Black Coffee on Cognition and Mood in Healthy Young and Older Adults”. Nutrients10 (2018): 1386.
    37. Fredholm BB., et al. “Actions of Caffeine in the Brain with Special Reference to Factors that Contribute to its Widespread Use”. Pharmacological Reviews 1 (1999): 83-133.
    38. Smit HJ and Rogers PJ. “Effects of Low Doses of Caffeine on Cognitive Performance, Mood and Thirst in Low and Higher Caffeine Consumers”. Psychopharmacology2 (2000): 167-173.
    39. Haskell CF., et al. “Cognitive and Mood Improvements of Caffeine in Habitual Consumers and Habitual Non-Consumers of Caffeine”. Psychopharmacology 4 (2005): 813-825.
    40. Childs E and De Wit H. “Subjective, Behavioral, and Physiological Effects of Acute Caffeine in Light, Nondependent Caffeine Users”. Psychopharmacology 4 (2006): 514-523.
    41. Prediger RDS. “Effects of Caffeine in Parkinson’s Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms”. Journal of Alzheimer's Disease 1 (2010): S205-S220.
    42. Greenland JC and Barker RA. “The Differential Diagnosis of Parkinson’s Disease”. In: Parkinson’s Disease: Pathogenesis and Clinical Aspects. Codon Publications (2018): 109-128.
    43. Kolahdouzan M and Hamadeh MJ. “The Neuroprotective Effects of Caffeine in Neurodegenerative Diseases”. CNS Neuroscience and Therapeutics 4 (2017): 272-290.
    44. Wierzejska R. “Can Coffee Consumption Lower the Risk of Alzheimer’s Disease and Parkinson’s Disease? A Literature Review”. Archives of Medical Science 3 (2017): 507-514.
    45. Palacios N., et al. “Caffeine and Risk of Parkinson’s Disease in a Large Cohort of Men and Women”. Movement Disorders 10 (2012): 1276-1282.
    46. Qi H and Li S. “Dose-Response Meta-Analysis on Coffee, Tea and Caffeine Consumption with Risk of Parkinson’s Disease”. Geriatrics and Gerontology International 2 (2014): 430-439.
    47. Cho B-H., et al. “Association of Coffee Consumption and Non-Motor Symptoms in Drug-Naïve, Early-Stage Parkinson’s Disease”. Parkinsonism and Related Disorders 50 (2018): 42-47.
    48. Cho B-H., et al. “Gender-Dependent Effect of Coffee Consumption on Tremor Severity in De Novo Parkinson’s Disease”. BMC Neurology 1 (2019): 194.
    49. Maughan RJ and Griffin J. “Caffeine Ingestion and Fluid Balance: A Review”. Journal of Human Nutrition and Dietetics 6 (2003): 411-420.
    50. Shirley DG., et al. “Natriuretic Effect of Caffeine: Assessment of Segmental Sodium Reabsorption in Humans”. Clinical Science 5 (2002): 461-466.
    51. Rieg T., et al. “Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine”. Journal of Pharmacology and Experimental Therapeutics 1 (2005): 403-409.
    52. Seal AD., et al. “Coffee with High but Not Low Caffeine Content Augments Fluid and Electrolyte Excretion at Rest”. Frontiers in Nutrition 4 (2017): 40.
    53. Vijaya T., et al. “Urolithiasis and Its Causes - Short Review”. The Journal of Phytopharmacology 3 (2013): 1-6.
    54. Hess B. “Nutritional Aspects of Stone Disease”. Endocrinology and Metabolism Clinics of North America 4 (2002): 1017-1030.
    55. Porowski T., et al. “Upper Metastable Limit Osmolality of Urine as a Predictor of Kidney Stone Formation in Children”. Urolithiasis2 (2019): 155-163.
    56. Barghouthy Y., et al. “Tea and Coffee Consumption and the Risk of Urinary Stones A Systematic Review of the Epidemiological Data”. World Journal of Urology (2021): 10.1007/s00345-020-03561-w.
Citation: Maurice HT Ling., et al. “Coffee as a Potential Nutraceutical”. EC Nutrition 16.3 (2021): 57-65.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 21, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to